METHODS OF TREATING OPHTHALMIC DISEASES USING NPR-B AGONISTS

摘要

Disclosed are novel compounds having NPR-B agonistic activity. Preferred compounds are linear peptides containing 8-13 conventional or non-conventional L- or D-amino acid residues connected to one another via peptide bonds.